Drug · DIN 02245464
BLES
SINGLE-USE VIALS
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 5, 2002; first marketed February 5, 2002.
- Drug Identification Number (DIN)
- 02245464
- Company (DIN owner)
- Bles Biochemicals IncLondon, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Suspension
- Route
- Intratracheal
- Therapeutic class (ATC)
- Natural phospholipids R07AA02
- Class
- Human
- Record last updated
- August 10, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PHOSPHOLIPID | 27 MG | ML |
| SURFACTANT-ASSOCIATED PROTEINS SP-B AND SP-C | 500 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 4, 2002: NOC 773New Drug Submission (NDS)